Table 2.
A comparison between amphetamines and cathinone on known neuroendocrine appetite modulating factors.
Amphetamines | Khat/Cathinone | |
---|---|---|
Appetite Inducing | ||
Neuropeptide Y (NPY) | AE1–4 | -- |
Norepinephrine | AE5–9 | AE10,11 |
Aguoti related peptide (AgRP) | -- | -- |
Orexin A & B | AE-NA12–14 | -- |
Melanin concentrating hormone (MCH) | -- | -- |
Ghrelin | AE-NA15,16 | HE17 |
Appetite Suppressing | ||
Proopiomelanocortin (POMC) | AE18,19 | -- |
Cocaine and amphetamine regulated transcript (CART) | AE20,21 | -- |
Leptin | AE-NA22 | AE23 HE24 |
Thyrotropin releasing hormone (TRH) | AE25,26 | -- |
Melanin | AE-NA27 | -- |
Corticotrophin releasing hormone (CRH) | AE-NA27 | -- |
Bombesin | AE28 | -- |
Glucagon | AE-NA29 | -- |
Glucagon-like peptide-1 (GLP-1) | AE-NA30 | -- |
Peptide YY (PYY) | AE28 | HE17 |
Apolipoprotein A-IV | -- | -- |
Amylin | -- | -- |
Somatostatin | AE-NA31 | -- |
Enterostatin | -- | -- |
Ciliary neurotrophic factor (CNF) | -- | -- |
Serotonin | AE32–35 HE38 HO39 |
AE36,37 |
NOTE: Abbreviations include AE = Animal Experimental, AE-NA = Animal Experimental Not Appetite specific, HE = Human Experimental, HO = Human observational studies. Select references are shown but are not meant to be comprehensive.
Cleary and Docherty, 2003; Harris and Baldessarini, 1973; Heikkila et al., 1975; Holmes and Rutledge, 1976; Kalix, 1983;
Hao et al., 2004;